...
首页> 外文期刊>Microbial Cell Factories >One-step affinity purification of fusion proteins with optimal monodispersity and biological activity: application to aggregation-prone HPV E6 proteins
【24h】

One-step affinity purification of fusion proteins with optimal monodispersity and biological activity: application to aggregation-prone HPV E6 proteins

机译:一步亲和纯化具有最佳单分散性和生物活性的融合蛋白:应用于易于聚集的HPV E6蛋白

获取原文

摘要

Bacterial expression and purification of recombinant proteins under homogeneous active form is often challenging. Fusion to highly soluble carrier proteins such as Maltose Binding Protein (MBP) often improves their folding and solubility, but self-association may still occur. For instance, HPV E6 oncoproteins, when produced as MBP-E6 fusions, are expressed as mixtures of biologically inactive oligomers and active monomers. While a protocol was previously developed to isolate MBP-E6 monomers for structural studies, it allows the purification of only one MBP-E6 construct at the time. Here, we explored a parallelizable strategy more adapted for biophysical assays aiming at comparing different E6 proteins. In this study, we took advantage of the distinct size and diffusion properties of MBP-E6 monomers and oligomers to separate these two species using a rapid batch preparation protocol on affinity resins. We optimized resin reticulation, contact time and elution method in order to maximize the proportion of monomeric MBP-E6 in the final sample. Analytical size-exclusion chromatography was used to quantify the different protein species after purification. Thus, we developed a rapid, single-step protocol for the parallel purification of highly monomeric MBP-E6 samples. MBP-fused HPV16 E6 samples obtained by this approach were validated by testing the binding to their prototypical peptide targets (the LXXLL motif from ubiquitine ligase E6AP) by BIAcore-SPR assay. We have designed a rapid single-step batch affinity purification approach to isolate biologically active monomers of MBP-fused E6 proteins. This protocol should be generalizable to isolate the monomer (or the minimal biologically active oligomer) of other proteins prone to self-association.
机译:均相活性形式下重组蛋白的细菌表达和纯化通常具有挑战性。与高可溶性载体蛋白(如麦芽糖结合蛋白(MBP))的融合通常会改善其折叠性和溶解性,但仍可能发生自缔合。例如,HPV E6癌蛋白当以MBP-E6融合形式产生时,被表达为生物惰性寡聚物和活性单体的混合物。虽然先前已开发出用于分离MBP-E6单体以进行结构研究的方案,但该方案当时仅可纯化一个MBP-E6构建体。在这里,我们探索了一种可并行化的策略,该策略更适合于生物物理测定,旨在比较不同的E6蛋白。在这项研究中,我们利用MBP-E6单体和低聚物的独特大小和扩散特性,利用在亲和树脂上的快速批制备方案来分离这两种物质。我们优化了树脂网状结构,接触时间和洗脱方法,以最大程度地提高最终样品中单体MBP-E6的比例。分析型尺寸排阻色谱用于定量纯化后的不同蛋白质种类。因此,我们开发了一种快速的单步骤方案,用于并行纯化高度单体的MBP-E6样品。通过BIAcore-SPR分析测试通过测试与原型肽靶标(来自泛素连接酶E6AP的LXXLL基序)的结合,可以验证通过该方法获得的MBP融合HPV16 E6样品。我们设计了一种快速的单步批量亲和纯化方法,以分离MBP融合E6蛋白的生物活性单体。该规程应该是可推广的,以分离易于自缔合的其他蛋白质的单体(或最小的生物活性寡聚体)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号